Inflammation metalloproteases

The anthrax toxin is a tripartite toxin and consists ofthe binding component protective antigen (PA), the lethal factor (LF), which is a metalloprotease, and the edema factor (EF), which is a calmodulin-dependent adenylyl-cyclase. Both enzyme components are translocated via PA into target cells. PA is activated by furin-induced cleavage and forms heptamers, which are similar to the binding components of C2 toxin and iota toxin. In the low pH compartment of endosomes, the heptamers form pores to allow translocation of LF and EF. LF cleaves six of the seven MEKs (MAPK-kinases) thereby inhibiting these enzymes. The functional consequence is the blockade of the MAPK pathways that control cell proliferation, differentiation, inflammation, stress response, and survival. Whether this is the reason for the LT-induced cell death of macrophages is not clear [1]. 

T cell activation in the lamina propria is associated with epithelial cell shedding, leading to loss of villi. It has been postulated that this is mediated by increased production of matrix metalloproteases (MMP), which, by degrading the lamina propria matrix, represent a major pathway by which T cells cause injury in the gut (Pender et al., 1997). Production of MMPs also facilitates movement of cells out of the vasculature into sites of inflammation and contributes substantially to the degradation of connective tissue during inflammatory disease (Stetler-Stevenson, 1996). Furthermore, MMPs are required for the release of soluble TNF-a from its membrane... 

T-Kininogen (TK) (single chain glycoproteins Cystatin-like domains) Metalloproteases (MPRs) Angiotensin-I converting enzyme (ACE) Bradykinin inflammation, vascular regulation, vasodilation] 13.5C-D 13.5C... 

Matrix metalloproteases (MMP) are also inhibited by hydroxamic acids and/or thiols. Over 25 variants of these enzymes are known, and some are involved in diseases ranging from inflammation to metastatic cancer (108). MMPs contain a zinc ion in the active site and function through the metallopeptidases catalytic mechanism already discussed. However, subtle differences between enzymes enable selective inhibitors to be developed (109). Fig. 15.25 lists some of the reported MMP inhibitors that use carboxylic acid (52-53), a hydroxamic acid (54-55), or thiol groups (56)as metal chelators. 

Compounds which reduce UV-induced oxidative damage and other symptoms such as skin inflammations and erythema by mediating the prevention of thymine dimer formation and inhibition of matrix metalloproteases. 

---